Icaritin

DB12672InvestigationalSmall molecule

Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).

Chemical structure of Icaritin
Formula / weight
C21H20O6 · 368.385 g/mol (avg)

Resolves to

Compound
UNIIUFE666UELYCAS118525-40-9ChEMBLCHEMBL498485PubChem5318980
Structure
InChIKeyTUUXBSASAQJECY-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1
Targets
P03372ESR1

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Icaritin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In